Savitz Ryan
EVP, CFO & CBO · 20 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-09 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Sale | 15,329 | $101.24 | $1.6M | filing |
| 2026-07-09 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Sale | 10,354 | $100.22 | $1.0M | filing |
| 2026-07-09 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Option exercise | 31,249 | $21.77 | $680,290.73 | filing |
| 2026-07-09 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Sale | 5,566 | $101.97 | $567,565.02 | filing |
| 2026-04-09 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Sale | 8,224 | $89.84 | $738,844.16 | filing |
| 2026-04-09 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Option exercise | 8,224 | $17.88 | $147,045.12 | filing |
| 2026-03-31 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Sale | 59,800 | $83.90 | $5.0M | filing |
| 2026-03-31 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Sale | 21,825 | $78.86 | $1.7M | filing |
| 2026-03-31 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Sale | 19,469 | $84.57 | $1.6M | filing |
| 2026-03-31 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Option exercise | 40,000 | $17.88 | $715,200.00 | filing |
| 2026-03-31 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Option exercise | 74,367 | $8.44 | $627,657.48 | filing |
| 2026-03-31 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Sale | 7,232 | $85.54 | $618,625.28 | filing |
| 2026-03-31 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Sale | 2,366 | $82.84 | $195,999.44 | filing |
| 2026-03-31 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Sale | 1,485 | $80.25 | $119,171.25 | filing |
| 2026-03-31 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Sale | 1,390 | $78.33 | $108,878.70 | filing |
| 2026-03-31 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Sale | 800 | $81.36 | $65,088.00 | filing |
| 2025-12-04 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Sale | 20,000 | $45.18 | $903,600.00 | filing |
| 2025-12-04 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Option exercise | 20,000 | $8.44 | $168,800.00 | filing |
| 2025-09-09 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Sale | 20,000 | $35.00 | $700,000.00 | filing |
| 2025-09-09 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Option exercise | 20,000 | $8.44 | $168,800.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.